Home » Psychology news » First in-human study of drug targeting brain inflammation supports further development
First in-human study of drug targeting brain inflammation supports further development
April 9, 2020 by NewsBot
MW189 blocks abnormal inflammation in the brain that is known to contribute to injury- and disease-induced neurologic impairments in a number of acute and chronic brain disorders. This study examined MW189 in healthy adult volunteers.
